Dr. Christine Pan, M.D.
What this data tells you about Dr. Pan
Dr. Christine Pan is an obstetrics & gynecology in Houston, TX, with 13 years in practice. Based on federal Medicare data, Dr. Pan performed 4,002 Medicare services across 1,312 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pan received a total of $10,355 from 25 pharmaceutical and/or device companies across 90 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 2,400 | $5 | $11 |
| Chronic care management, first 20 min/month | 241 | $39 | $119 |
| PSA test (prostate cancer screening) | 184 | $18 | $76 |
| Office visit, established patient (30-39 min) | 149 | $75 | $260 |
| Urine culture, bacterial colony count | 144 | $8 | $33 |
| Insertion of temporary bladder tube | 104 | $28 | $218 |
| Urine culture, bacterial identification | 97 | $8 | $34 |
| Automated urinalysis | 85 | $2 | $10 |
| Antibiotic sensitivity test | 83 | $8 | $36 |
| New patient office visit (45-59 min) | 73 | $99 | $410 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $45 | $209 |
| Office visit, established patient (20-29 min) | 53 | $53 | $180 |
| Testosterone (hormone) level, total | 51 | $25 | $106 |
| Bladder ultrasound after voiding | 46 | $6 | $72 |
| Office visit, established patient, complex (40-54 min) | 26 | $142 | $404 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 23 | $260 | $1,175 |
| Cell examination of specimen, selective cellular enhancement technique | 22 | $38 | $205 |
| Psa (prostate specific antigen) measurement, free | 21 | $18 | $76 |
| Measurement of total estradiol (hormone) | 19 | $27 | $115 |
| Sex hormone binding globulin (protein) level | 19 | $21 | $89 |
| Red blood cell concentration measurement | 17 | $2 | $10 |
| New patient office visit, complex (60-74 min) | 15 | $159 | $572 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 14 | $114 | $853 |
| Comprehensive metabolic blood panel | 12 | $10 | $43 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 11 | $247 | $1,085 |
| Electronic assessment of bladder emptying | 11 | $5 | $291 |
| Insertion of device into abdomen with pressure and urine flow rate study | 11 | $135 | $552 |
| Prostate cancer screening; prostate specific antigen test (psa) | 11 | $17 | $75 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in obstetrics & gynecology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for obstetrics & gynecology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pan is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 6%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pan experienced with botox injection, per unit?
Does Dr. Pan receive payments from pharmaceutical companies?
How do Dr. Pan's costs compare to other obstetrics & gynecologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology